Enhancing effect of quercetin on 3-methylcholanthrene carcinogenesis in C57Bl/6 mice. 1985

M Ishikawa, and T Oikawa, and M Hosokawa, and J Hamada, and K Morikawa, and H Kobayashi

We investigated the effect of quercetin on 3-methylcholanthrene (MCA) carcinogenesis in C57Bl/6 mice. We found that quercetin itself was not carcinogenic when administered i.m., even at a dose of 20 mg, throughout an observation period of 420 days. An i.m. administration of various doses of quercetin admixed with 1.0 mg of MCA, however, significantly shortened the mean latency periods for the development of local primary tumors compared with those of the group which had been given MCA alone. The shortening of latency periods was also found in the experiments using 0.1 mg of MCA after the administration of quercetin either admixed with MCA or fed with a diet containing it. Moreover, lung metastasis increased in mice given the mixture of MCA (0.1 mg) and quercetin compared with its occurrence in mice given MCA alone. A simultaneous administration of MCA and quercetin significantly increased the in vivo sister chromatid exchanges (SCE) formation of bone marrow cells when compared with its occurrence in the group given MCA alone. These results suggest that quercetin has an enhancing effect on MCA carcinogenesis and that this enhancement may be associated with such a genetic effect as an increased mutation rate in the host.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008748 Methylcholanthrene A carcinogen that is often used in experimental cancer studies. 20-Methylcholanthrene,3-Methylcholanthrene,20 Methylcholanthrene,3 Methylcholanthrene
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D011794 Quercetin A flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin. 3,3',4',5,7-Pentahydroxyflavone,Dikvertin
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D003043 Cocarcinogenesis The combination of two or more different factors in the production of cancer. Cocarcinogeneses
D005260 Female Females
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M Ishikawa, and T Oikawa, and M Hosokawa, and J Hamada, and K Morikawa, and H Kobayashi
December 1976, Journal of the National Cancer Institute,
M Ishikawa, and T Oikawa, and M Hosokawa, and J Hamada, and K Morikawa, and H Kobayashi
January 1981, International journal of cancer,
M Ishikawa, and T Oikawa, and M Hosokawa, and J Hamada, and K Morikawa, and H Kobayashi
December 1975, Gan,
M Ishikawa, and T Oikawa, and M Hosokawa, and J Hamada, and K Morikawa, and H Kobayashi
January 1988, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer,
M Ishikawa, and T Oikawa, and M Hosokawa, and J Hamada, and K Morikawa, and H Kobayashi
December 1999, Medical microbiology and immunology,
M Ishikawa, and T Oikawa, and M Hosokawa, and J Hamada, and K Morikawa, and H Kobayashi
September 2016, Journal of cancer prevention,
M Ishikawa, and T Oikawa, and M Hosokawa, and J Hamada, and K Morikawa, and H Kobayashi
January 1976, Voprosy onkologii,
M Ishikawa, and T Oikawa, and M Hosokawa, and J Hamada, and K Morikawa, and H Kobayashi
July 1955, Cancer research,
M Ishikawa, and T Oikawa, and M Hosokawa, and J Hamada, and K Morikawa, and H Kobayashi
August 1963, Cancer research,
M Ishikawa, and T Oikawa, and M Hosokawa, and J Hamada, and K Morikawa, and H Kobayashi
August 1977, International journal of cancer,
Copied contents to your clipboard!